Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2270 participants.
Also called NCT03968393
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 2,270 participants
- Registry
-
NCT03968393 -
2023-509142-35-00 -
2019-001336-62
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Argentina, Australia, Brazil, Canada, Denmark, Finland, Germany, India, Italy, Nepal, Netherlands, Pakistan, South Korea, Spain, Sweden, Switzerland, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT03968393. Randomized; single masking; primary purpose prevention. Start 2019-06-14 (actual); primary completion 2028-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- Acronym
- ASPIRE-AF
- Condition
- Stroke
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Non-vitamin K oral anticoagulant (NOAC)
- Lead sponsor
- Population Health Research Institute
- Collaborator
- Hamilton Health Sciences Corporation
Record details
- Record id
cardio:ct-nct03968393- Content hash
6d948720d90d816b95de10506f0b5c3e9a488764b1008d9de619a8a2f38fc070